Comparison among Different Types, Dosages and Duration of Interferon Therapy in Chronic Hepatitis C

Author： Bresci G. Parisi G. Metrangolo S. Bertoni M. Capria A.

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.15, Iss.4, 1998-04, pp. : 271-277

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incidence of Side Effects During Therapy with Different Types of Alpha Interferon: A Randomised Controlled Trial Comparing Recombinant Alpha 2b Versus Leukocyte Interferon in the Therapy of Naive Patients with Chronic Hepatitis C

Current Pharmaceutical Design, Vol. 8, Iss. 11, 2002-05 ,pp. : 977-980

Bentham Science Publishers

Access to resources Recommend Favorite

Psychiatric Symptoms Induced by Antiviral Therapy in Chronic Hepatitis C: Comparison between Interferon-α-2a and Interferon-α-2b

By Neri Sergio Pulvirenti Davide Bertino Gaetano

Clinical Drug Investigation, Vol. 26, Iss. 11, 2006-01 ,pp. : 655-662

Adis International

Access to resources Recommend Favorite

Pegylated interferon with ribavirin therapy for chronic infection with the hepatitis C virus

By Foster Graham R

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 685-691

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Pegylated Interferon Antiviral Therapy of Chronic Hepatitis C

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 5, Iss. 4, 2006-10 ,pp. : 379-387

Bentham Science Publishers

Access to resources Recommend Favorite

Randomised Trial of Two Different Daily Doses of Interferon- versus Classical Therapy in Treatment-Naïve Patients with Chronic Hepatitis C

By Montalto G.

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 623-631

Adis International

Access to resources Recommend Favorite